Air pollution and pulmonary function in asthmatic children: effects of prenatal and lifetime exposures

Kathleen Mortimer1, Romain Neugebauer, Frederick Lurmann

  • 1Divisions of aEpidemiology, School of Public Health, University of California, Berkeley, CA 4720-7370, USA. kmort@berkeley.edu

Insights

Prenatal exposure to air pollutants like carbon monoxide (CO), particulate matter (PM10), and nitrogen dioxide (NO2) can negatively impact lung function in children with asthma, especially in vulnerable subgroups.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Toxicology

Background:

  • Prenatal and early life are critical periods for lung development, susceptible to oxidant pollutant-induced remodeling.
  • Asthma management is complex, with environmental factors playing a significant role in disease progression.

Purpose of the Study:

  • To investigate the association between prenatal and lifetime air pollutant exposures and pulmonary function in children with asthma.
  • To identify specific air pollutants and exposure windows impacting lung function in this cohort.

Main Methods:

  • Reconstructed prenatal and lifetime air pollutant exposures (Ozone, CO, NO2, PM10) for 232 asthmatic children.
  • Utilized geocoding of residences and developed predictive models for 8 pulmonary function measures.
  • Employed a novel Deletion/Substitution/Addition algorithm for model selection.

Main Results:

  • Second-trimester NO2 exposure linked to reduced FVC and FEV1; first-trimester PM10 linked to reduced PEF.
  • Early-life CO exposure negatively affected FEV1/FVC and FEF25-75/FVC.
  • Effects were more pronounced in subgroups: African American children, those diagnosed before age 2, and those with prenatal maternal smoking exposure.

Conclusions:

  • Prenatal and early-life exposure to CO, PM10, and NO2 adversely affects pulmonary function in specific subgroups of asthmatic children.
  • Highlights the importance of early life environmental exposures in pediatric asthma management and prevention strategies.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...